Talal Alabduljalil1, Rachel C Patel2, Abdullah A Alqahtani3, Simon S Gao4, Michael J Gale2, Miao Zhang5, Yali Jia2, David Huang2, Pei-Wen Chiang2, Rui Chen6, Jun Wang6, Richard G Weleber2, Mark E Pennesi2, Paul Yang7. 1. Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA; Albahar Eye Center, Ibn Sina Hospital, Ministry of Health, Kuwait. 2. Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA. 3. Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA; Department of Ophthalmology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. 4. Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA; Genentech, South San Francisco, California, USA. 5. Topcon Healthcare Solutions, Milpitas, California, USA. 6. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA. 7. Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA. Electronic address: yangp@ohsu.edu.
Abstract
PURPOSE: This study measured and correlated degeneration of the junction between the inner and outer segments (IS/OS), the retinal pigment epithelium (RPE), and the choriocapillaris (CC) in Stargardt disease (STGD). DESIGN: Prospective cross-sectional study. METHODS: This study was conducted at the Casey Eye Institute. A total of 23 patients with STGD were enrolled and underwent optical coherence tomography angiography (OCTA). Scans were centered on the fovea. OCT slab projections and en face boundary maps were used to create masks to measure total IS/OS loss or RPE atrophy as well as regions of isolated IS/OS loss, isolated RPE atrophy, and matched IS/OS and RPE degeneration or intact IS/OS junction and RPE. CC vascular density (CCVD) was quantified from the CC angiogram. Outcomes included the area of loss, and the CCVD of degeneration in different areas was quantified and correlated. RESULTS: The total area of IS/OS loss was strongly correlated with the total area of RPE atrophy (r = 0.96; P < 0.0001) by a 1.6:1 ratio (r2 = 0.90). CCVD within regions of matched degeneration (85.6% ± 2.7%; P < 0.0001), isolated IS/OS junction loss (93.6% ± 1.0%; P = 0.0011), and isolated RPE atrophy (94.1% ± 1.1%; P = 0.0065) were all significantly lower than normal (99.0% ± 0.17%). There was a trend for CCVD within intact areas (97.6% ± 0.38%) to decline as the area diminished (r = 0.68). CONCLUSIONS: Photoreceptor and RPE degeneration exhibited a strong relationship wherein the IS/OS loss was 1.6-fold greater than that of RPE atrophy, supporting the theory that photoreceptor degeneration precedes RPE in STGD. Both the photoreceptors and the RPE degeneration contributed synergistically to CCVD attenuation, but extralesional CCVD also tended to be abnormal. The findings and techniques in this study may be of utility in developing endpoints for clinical trials.
PURPOSE: This study measured and correlated degeneration of the junction between the inner and outer segments (IS/OS), the retinal pigment epithelium (RPE), and the choriocapillaris (CC) in Stargardt disease (STGD). DESIGN: Prospective cross-sectional study. METHODS: This study was conducted at the Casey Eye Institute. A total of 23 patients with STGD were enrolled and underwent optical coherence tomography angiography (OCTA). Scans were centered on the fovea. OCT slab projections and en face boundary maps were used to create masks to measure total IS/OS loss or RPE atrophy as well as regions of isolated IS/OS loss, isolated RPE atrophy, and matched IS/OS and RPE degeneration or intact IS/OS junction and RPE. CC vascular density (CCVD) was quantified from the CC angiogram. Outcomes included the area of loss, and the CCVD of degeneration in different areas was quantified and correlated. RESULTS: The total area of IS/OS loss was strongly correlated with the total area of RPE atrophy (r = 0.96; P < 0.0001) by a 1.6:1 ratio (r2 = 0.90). CCVD within regions of matched degeneration (85.6% ± 2.7%; P < 0.0001), isolated IS/OS junction loss (93.6% ± 1.0%; P = 0.0011), and isolated RPE atrophy (94.1% ± 1.1%; P = 0.0065) were all significantly lower than normal (99.0% ± 0.17%). There was a trend for CCVD within intact areas (97.6% ± 0.38%) to decline as the area diminished (r = 0.68). CONCLUSIONS: Photoreceptor and RPE degeneration exhibited a strong relationship wherein the IS/OS loss was 1.6-fold greater than that of RPE atrophy, supporting the theory that photoreceptor degeneration precedes RPE in STGD. Both the photoreceptors and the RPE degeneration contributed synergistically to CCVD attenuation, but extralesional CCVD also tended to be abnormal. The findings and techniques in this study may be of utility in developing endpoints for clinical trials.
Authors: Miao Zhang; Jie Wang; Alex D Pechauer; Thomas S Hwang; Simon S Gao; Liang Liu; Li Liu; Steven T Bailey; David J Wilson; David Huang; Yali Jia Journal: Biomed Opt Express Date: 2015-11-02 Impact factor: 3.732
Authors: Stanley Lambertus; Ramon A C van Huet; Nathalie M Bax; Lies H Hoefsloot; Frans P M Cremers; Camiel J F Boon; B Jeroen Klevering; Carel B Hoyng Journal: Ophthalmology Date: 2014-10-17 Impact factor: 12.079
Authors: Kaoru Fujinami; Noemi Lois; Alice E Davidson; Donna S Mackay; Chris R Hogg; Edwin M Stone; Kazushige Tsunoda; Kazuo Tsubota; Catey Bunce; Anthony G Robson; Anthony T Moore; Andrew R Webster; Graham E Holder; Michel Michaelides Journal: Am J Ophthalmol Date: 2013-03-15 Impact factor: 5.258
Authors: Vivienne C Greenstein; Jason Nunez; Winston Lee; Kaspar Schuerch; Brad Fortune; Stephen H Tsang; Rando Allikmets; Janet R Sparrow; Donald C Hood Journal: Invest Ophthalmol Vis Sci Date: 2017-10-01 Impact factor: 4.799
Authors: Rodolfo Mastropasqua; Lisa Toto; Enrico Borrelli; Luca Di Antonio; Peter A Mattei; Alfonso Senatore; Marta Di Nicola; Cesare Mariotti Journal: PLoS One Date: 2017-02-02 Impact factor: 3.240
Authors: Maria A Parker; Laura R Erker; Isabelle Audo; Dongseok Choi; Saddek Mohand-Said; Kastytis Sestakauskas; Patrick Benoit; Terence Appelqvist; Melissa Krahmer; Caroline Ségaut-Prévost; Brandon J Lujan; Ambar Faridi; Elvira N Chegarnov; Peter N Steinkamp; Cristy Ku; Mariana Matioli da Palma; Pierre-Olivier Barale; Sarah Ayelo-Scheer; Andreas Lauer; Tim Stout; David J Wilson; Richard G Weleber; Mark E Pennesi; José Alain Sahel; Paul Yang Journal: Am J Ophthalmol Date: 2022-03-04 Impact factor: 5.488
Authors: Rodolfo Mastropasqua; Alfonso Senatore; Luca Di Antonio; Marta Di Nicola; Michele Marchioni; Fabiana Perna; Filippo Amore; Enrico Borrelli; Chiara De Nicola; Paolo Carpineto; Lisa Toto Journal: J Clin Med Date: 2019-09-10 Impact factor: 4.241
Authors: Debra A Thompson; Alessandro Iannaccone; Robin R Ali; Vadim Y Arshavsky; Isabelle Audo; James W B Bainbridge; Cagri G Besirli; David G Birch; Kari E Branham; Artur V Cideciyan; Steven P Daiger; Deniz Dalkara; Jacque L Duncan; Abigail T Fahim; John G Flannery; Roberto Gattegna; John R Heckenlively; Elise Heon; K Thiran Jayasundera; Naheed W Khan; Henry Klassen; Bart P Leroy; Robert S Molday; David C Musch; Mark E Pennesi; Simon M Petersen-Jones; Eric A Pierce; Rajesh C Rao; Thomas A Reh; Jose A Sahel; Dror Sharon; Paul A Sieving; Enrica Strettoi; Paul Yang; David N Zacks Journal: Transl Vis Sci Technol Date: 2020-06-03 Impact factor: 3.283
Authors: Malia M Edwards; Vera L Bonilha; Imran A Bhutto; Brent A Bell; D Scott McLeod; Joe G Hollyfield; Gerard A Lutty Journal: Invest Ophthalmol Vis Sci Date: 2020-07-01 Impact factor: 4.799
Authors: Nihaal Mehta; Phillip X Braun; Isaac Gendelman; A Yasin Alibhai; Malvika Arya; Jay S Duker; Nadia K Waheed Journal: Sci Rep Date: 2020-09-21 Impact factor: 4.379